{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T23:41:40Z","timestamp":1724370100482},"reference-count":26,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,2,1]]},"abstract":"<jats:p>Overproduction of thyroid hormones promotes bone resorption in vivo and in vitro, and we have evaluated whether mediators of such effects could include the osteotropic cytokines. Previous studies have demonstrated raised serum interleukin (IL)-6 in thyrotoxic patients, but differentiating the contribution of the elevated thyroid hormones from that of the autoimmune inflammation present in Graves\u2019 disease (GD) has been difficult. We undertook a longitudinal study of 34 patients (19\u201345 yr old) with GD, toxic nodular goiter (TNG), or a history of thyroid carcinoma but no evidence of disease recurrence, receiving sufficient T4 to suppress TSH. Controls were 12 euthyroid females. The following measurements were made basally and for 6 months after carbimazole treatment: serum free T4, T3, bone-specific alkaline phosphatase (b-ALP), IL-6, IL-8, IL-1\u03b2, tumor necrosis factor-\u03b1, IL-11, and urinary deoxypyridinoline (Udpd). Compared with controls (IL-6, 1.1 \u00b1 0.3 ng\/L; IL-8, 3.2 \u00b1 0.8 ng\/L), untreated patients with GD and TNG had elevated IL-6 (GD, 7.11 \u00b1 0.88 ng\/L; TNG, 7.30 \u00b1 0.77 ng\/L; P &amp;lt; 0.001) and IL-8 (GD, 10.3 \u00b1 1.23 ng\/L; TNG, 9.81 \u00b1 1.27 ng\/L; P &amp;lt; 0.001). These levels fell after treatment and were then indistinguishable from those in control subjects. Thyroid carcinoma patients on TSH suppressive therapy also had significantly raised levels of IL-6 (2.5 \u00b1 0.42 ng\/L) and IL-8 (4.4 \u00b1 0.63 ng\/L). When data from all the patients were pooled, the levels of IL-6 and IL-8 correlated with serum T3 and free T4 but not with Udpd or b-ALP. IL-1\u03b2, IL-11, and tumor necrosis factor-\u03b1 were not raised in any patient.<\/jats:p><jats:p>The elevations in serum IL-6 and -8 that occur in hyperthyroidism seem to result from the chronic effects of thyroid hormone excess rather than the accompanying autoimmune inflammatory condition produced by Graves\u2019 thyroid or eye disease. The site of the presumed increased production of IL-6 and -8 is most likely from bone osteoblasts, despite the inability of bone markers (such as Udpd and b-ALP) to correlate with acute changes in thyroid hormone status produced by antithyroid therapy.<\/jats:p>","DOI":"10.1210\/jcem.84.2.5436","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:03:55Z","timestamp":1389200635000},"page":"435-439","source":"Crossref","is-referenced-by-count":3,"title":["Serum Cytokines in Thyrotoxicosis1"],"prefix":"10.1210","volume":"84","author":[{"given":"A.","family":"Siddiqi","sequence":"first","affiliation":[{"name":"Departments of Clinical Biochemistry (A.S., J.M.B.), London E1 1BB, United Kingdom"},{"name":"Endocrinology (A.S., J.P.M., D.F.W., G.M.B., J.M.B.), St. Bartholomew\u2019s and Royal London School of Medicine and Dentistry, London E1 1BB, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Monson","sequence":"additional","affiliation":[{"name":"Endocrinology (A.S., J.P.M., D.F.W., G.M.B., J.M.B.), St. Bartholomew\u2019s and Royal London School of Medicine and Dentistry, London E1 1BB, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. F.","family":"Wood","sequence":"additional","affiliation":[{"name":"Endocrinology (A.S., J.P.M., D.F.W., G.M.B., J.M.B.), St. Bartholomew\u2019s and Royal London School of Medicine and Dentistry, London E1 1BB, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M.","family":"Besser","sequence":"additional","affiliation":[{"name":"Endocrinology (A.S., J.P.M., D.F.W., G.M.B., J.M.B.), St. Bartholomew\u2019s and Royal London School of Medicine and Dentistry, London E1 1BB, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Burrin","sequence":"additional","affiliation":[{"name":"Departments of Clinical Biochemistry (A.S., J.M.B.), London E1 1BB, United Kingdom"},{"name":"Endocrinology (A.S., J.P.M., D.F.W., G.M.B., J.M.B.), St. Bartholomew\u2019s and Royal London School of Medicine and Dentistry, London E1 1BB, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071618324318800_R1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1677\/joe.0.1330327","article-title":"Tri-iodothyronine stimulates rat osteoclastic bone resorption by an indirect effect.","volume":"133","author":"Allain","year":"1992","journal-title":"J Endocrinol"},{"key":"2020071618324318800_R2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1677\/joe.0.1570453","article-title":"T3 regulates the production of IL-6 and IL-8 in human bone marrow stromal and osteoblast-like cells.","volume":"157","author":"Siddiqi","year":"1998","journal-title":"J Endocrinol"},{"key":"2020071618324318800_R3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJM199502023320506","article-title":"Bone marrow, cytokines and bone remodelling.","volume":"332","author":"Manolagas","year":"1995","journal-title":"N Engl J Med"},{"key":"2020071618324318800_R4"},{"key":"2020071618324318800_R5","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.4049\/jimmunol.154.11.6065","article-title":"Macrophage inflammatory protein 1-a and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts.","volume":"154","author":"Fuller","year":"1995","journal-title":"J Immunol"},{"key":"2020071618324318800_R6","first-page":"2976","article-title":"Increased serum concentrations of IL-6 and soluble IL-6 receptor in patients with Graves\u2019 disease.","volume":"81","author":"Salvi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618324318800_R7","first-page":"78","article-title":"Serum IL-6 and bone metabolism in patients with thyroid function disorders.","volume":"82","author":"Lakatos","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618324318800_R8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1530\/eje.0.1320668","article-title":"Serum levels of IL-6 and TNF-a in hyperthyroid patients before and after propylthiouracil treatment.","volume":"132","author":"Celik","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"2020071618324318800_R9","author":"Trainer","year":"1995"},{"key":"2020071618324318800_R10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-1759(91)90063-L","article-title":"Sensitive ELISA for IL-6 -detection of IL-6 in biological fluids, synovial fluids and sera.","volume":"138","author":"Helle","year":"1991","journal-title":"J Immunol Methods"},{"key":"2020071618324318800_R11","first-page":"753","article-title":"A longitudinal study of markers of bone turnover in Graves\u2019 disease and their value in predicting bone mineral density.","volume":"82","author":"Siddiqi","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618324318800_R12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF03344951","article-title":"Increased serum IL-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration.","volume":"16","author":"Bartalena","year":"1993","journal-title":"J Endocrinol Invest"},{"key":"2020071618324318800_R13","first-page":"423","volume":"78","author":"Bartalena","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618324318800_R14","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1210\/jcem.79.5.7962338","volume":"79","author":"Bartalena","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618324318800_R15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/thy.1998.8.371","article-title":"IL-6 levels are not increased in women with postpartum thyroid dysfunction.","volume":"8","author":"Ahmed","year":"1998","journal-title":"Thyroid"},{"key":"2020071618324318800_R16","first-page":"370","article-title":"Lack of increased serum IL-6 and soluble IL-6 receptor concentration in patients with thyroid diseases following recombinant human interferon\u03b1 therapy.","volume":"44","author":"Minelli","year":"1996","journal-title":"J Invest Med"},{"key":"2020071618324318800_R17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/08916939708996275","article-title":"High circulating IL-6 level in Graves\u2019 opthalmopathy.","volume":"25","author":"Molnar","year":"1997","journal-title":"Autoimmunity"},{"key":"2020071618324318800_R18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/oxfordjournals.annonc.a059218","article-title":"Serum cytokine levels correlate with clinical parameters in Hodgkin\u2019s disease.","volume":"6","author":"Gorschluter","year":"1995","journal-title":"Ann Oncol"},{"key":"2020071618324318800_R19","first-page":"155","article-title":"Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies.","volume":"14","author":"Schlaak","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"2020071618324318800_R20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1210\/jcem-72-5-1113","article-title":"A study of the serum concentration of TNF-\u03b1 in thyroidal and non-thyroidal illnesses.","volume":"72","author":"Chopra","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618324318800_R21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/thy.1996.6.97","article-title":"Different cytokine mRNA profiles in Graves\u2019 disease, Hashimoto\u2019s thyroiditis and non-autoimmune thyroid disorders determined by quantitative RT-PCR.","volume":"6","author":"Heuer","year":"1996","journal-title":"Thyroid"},{"key":"2020071618324318800_R22","first-page":"818","article-title":"Carefully monitored thyroxine suppressive therapy is not associated with bone loss in premenopausal women.","volume":"78","author":"Marcocci","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618324318800_R23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1530\/eje.0.1340702","article-title":"Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy.","volume":"134","author":"Langdahl","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"2020071618324318800_R24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2265.1994.tb02572.x","article-title":"Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.","volume":"41","author":"Franklyn","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618324318800_R25","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archinte.152.2.360","article-title":"Borderline-low serum thyrotropin level is correlated with increased fasting urinary hydroxyproline excretion.","volume":"152","author":"Krakauer","year":"1992","journal-title":"Arch Intern Med"},{"key":"2020071618324318800_R26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archinte.1983.00350030052010","article-title":"Exogenous hyperthyroidism with osteoporosis.","volume":"143","author":"Fallon","year":"1983","journal-title":"Arch Intern Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/84\/2\/435\/13122338\/jcem0435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/84\/2\/435\/13122338\/jcem0435.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T14:54:05Z","timestamp":1688914445000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/84\/2\/435\/2864136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2,1]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.84.2.5436","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2,1]]}}}